Villarta, Genelyn .
HRN: 28-25-07 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/29/2025
AMPICILLIN 1GM (VIAL)
12/29/2025
01/05/2026
IV
2g
Q6h
PROM
Checking Initial Appropriateness
12/30/2025
CEFUROXIME 500MG (TAB)
12/30/2025
01/06/2026
PO
500
Bid
Uti
Checking Final Appropriateness